Francis Collins
Showing 16–18 of 18 transcripts.
- Milken Institute1h 12m
Lunch Panel: A Cure for What Ails Us: Celebrating the Impact of Science
Nancy Brown, Francis Collins, Thomas Frieden, Andrew von Eschenbach, Michael Milken
The bioscience forum highlighted the sector's massive contribution to increased global life expectancy and economic growth while emphasizing that flat budgets and inflation have critically reduced NIH grant success rates to below 20%. Distinguished leaders such as Francis Collins and Tom Frieden warned that sustained funding cuts and a 90% treatment-versus-prevention spending imbalance threaten American innovation and the careers of young researchers. Despite these financial constraints, the event underscored significant breakthroughs in areas like genomic medicine and disease eradication, with panelists urging renewed investment to maintain global health leadership and drive future discoveries.
- Milken Institute1h 0m
Bioscience Discoveries That Will Blow Your Mind
Jack Andraka, David Baltimore, Francis Collins, Tejal Desai, Aydogan Ozcan, Margaret Anderson
A panel of leading scientists including Jack Andraka, Tejal Desai, David Baltimore, and Francis Collins outlined breakthrough innovations in cancer detection, gene therapy, and nanotechnology while highlighting the transformative potential of open-access data. Despite rapid advancements in genomic sequencing and portable diagnostics, experts warned of a critical decline in U.S. biomedical funding that is discouraging young researchers from pursuing high-risk scientific careers. The discussion concluded with calls to establish special grant programs for early-career innovators and to restore emphasis on curiosity-driven education to sustain future scientific progress.
- Milken Institute1h 15m
The Promise of the Bioscience Century
Paul Irving, Mike Milken, Eric Cantor, Paul Chu, Jeff, Bernardo Zavala, Jr., Bernard Harris, Andy von Eschenbach, Peggy, Francis Collins, Chris Austin
This event analyzes the critical role of bioscience in driving global economic growth and societal well-being while highlighting China's aggressive $308 billion investment program that threatens to surpass U.S. leadership. Panelists discuss strategic institutional responses, such as DARPA's high-risk research model and the FDA's regulatory innovations, which have accelerated breakthroughs in prosthetics, personalized medicine, and disease prevention. However, fiscal constraints and shifting global demographics necessitate sustained bipartisan funding to preserve the United States' status as a central hub for scientific innovation and global health security.